Results 251 to 260 of about 117,037 (362)

Are Children with Cystic Fibrosis Who Are Treated With a Proton-Pump Inhibitor at Risk for Vitamin B 12 Deficiency?

open access: bronze, 2001
Henriëtte ter Heide   +6 more
openalex   +1 more source

Modulating Molecular Aggregations via Konjac Glucomannan for High‐Contrast Time‐Dependent Phosphorescence Color

open access: yesAggregate, EarlyView.
An ingenious design strategy is developed to construct high‐contrast time‐dependent phosphorescence color (TDPC) materials ranging from red to blue‐green via a facile molecular aggregation regulation strategy. PyC‐KGM with excellent TDPC performance, decent rheological properties, and environmental friendliness has been successfully applied to screen ...
Ping Wu   +8 more
wiley   +1 more source

Molecular Design and Redox Chemistries for Aqueous Organic Redox Flow Batteries (AORFBs)

open access: yesAngewandte Chemie, EarlyView.
Aqueous organic redox flow batteries (AORFBs) are a promising frontier for sustainable long‐duration energy storage. This review highlights recent advances in redox‐active molecule design, structure‐property relationships, and degradation mechanisms, alongside pairing strategies and full‐cell engineering.
Pan Wang
wiley   +2 more sources

Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents. [PDF]

open access: yesJ Gastroenterol Hepatol
Shibata H   +16 more
europepmc   +1 more source

Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined

open access: yesAggregate, EarlyView.
Non‐neoplastic diseases pose a significant health burden. Nanozymes, enzyme‐like nanomaterials, offer promising strategies for regulating oxidative stress and inflammation. This review explores their development, structure–function relationships, and therapeutic potential, with a focus on precision medicine through targeted delivery and multimodal ...
Ling Mei   +8 more
wiley   +1 more source

COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDs

open access: bronze, 2001
Kam‐Chuen Lai   +11 more
openalex   +1 more source

Promotion of 5‐hydroxymethylfurfural synthesis from glucose over AlCl3 catalyst with choline chloride

open access: yesAIChE Journal, EarlyView.
Abstract Efficient production of 5‐hydroxymethylfurfural (HMF) from glucose was achieved in a water‐methyl isobutyl ketone biphasic solvent system over AlCl3 catalyst, using a green and cheap choline chloride (ChCl) salt as a promoter. An optimized HMF yield of 67% was obtained from 0.6 M glucose over 0.06 M AlCl3 with 3.8 M ChCl addition at 140°C ...
Chencong Ruan, Hero Jan Heeres, Jun Yue
wiley   +1 more source

Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use. [PDF]

open access: yesOncologist
Chen BF   +11 more
europepmc   +1 more source

MEW/PVA‐MA Hydrogel Vascular Grafts: Enhancing Hemocompatibility and Endothelialization

open access: yesAdvanced NanoBiomed Research, EarlyView.
A biomimetic vascular graft combining biofunctionalized PVA‐MA hydrogels with a MEW scaffold is developed for small‐diameter applications. Gel‐MA and Hep‐MA incorporation enhances endothelialization and hemocompatibility, respectively, targeting the acute biological responses.
Verena Kronberger   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy